$8.01
-0.11-1.35%
At close: -
$8.02
0.010000.12%
After Hours: 5:12 PM EDT
Comments
Loading...
Avadel Pharmaceuticals Stock Guidance | NASDAQ:AVDL | Benzinga
Avadel Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/03/2025 | AVDL | Avadel Pharmaceuticals | FY | 2025 | — | — | — | $240.00M | $260.00M | $250.35M | Get Alert |
| 01/08/2025 | AVDL | Avadel Pharmaceuticals | FY | 2024 | — | — | — | $169.00M | $169.00M | $171.41M | Get Alert |
| 01/08/2025 | AVDL | Avadel Pharmaceuticals | Q4 | 2024 | — | — | — | $50.00M | $50.00M | $52.70M | Get Alert |
| 01/08/2025 | AVDL | Avadel Pharmaceuticals | FY | 2025 | — | — | — | $240.00M | $260.00M | $291.34M | Get Alert |
FAQ
What is the most recent guidance for Avadel Pharmaceuticals (AVDL)?
There have been no specific sales or earnings guidance reported for Avadel Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.